2025 annual financial data
Lisata Therapeutics 2025 Operating margin
Lisata Therapeutics 2025 operating margin with verified reported values.
Direct answer
Operating margin was -10,711.18%.
Operating income was -18,209,000 USD and net income was -16,586,000 USD.
Operating cash flow was -15,949,000 USD.
Get free Lisata Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 170,000 USD
- Operating income
- -18,209,000 USD
- Net income
- -16,586,000 USD
- Operating cash flow
- -15,949,000 USD